Bromodomain and extraterminal proteins - A novel class of therapeutic targets in epigenetics

Jin Jing Chen, Xiao Li Zhao, Zhen Wang, Lin-Feng Chen

Research output: Contribution to journalReview article

Abstract

Bromodomain and extraterminal (BET) proteins are a class of proteins that can interpret epigenetic codes and play an important role in regulating gene transcription through identifying and binding acetylated histones or non-histones proteins. The BET inhibitors have emerged with good therapeutic effects in preclinical disease models such as cancer and inflammation. Some of them have entered clinical studies, demonstrating that there is considerable prospect for drug development with BET as a potential therapeutic target. This review briefly describes the structures and functions of the BET proteins, the BET inhibitors in various diseases, as well as molecular mechanisms involved.

Original languageEnglish (US)
Pages (from-to)1209-1215
Number of pages7
JournalYaoxue Xuebao
Volume52
Issue number8
DOIs
StatePublished - Jan 1 2017

Fingerprint

Staphylococcal Protein A
Epigenomics
Proteins
Therapeutic Uses
Therapeutics
Histones
Inflammation
Pharmaceutical Preparations
Genes
Neoplasms

Keywords

  • Bromodomain and extraterminal
  • Bromodomain containing 4
  • Chromatin regulation
  • Epigenetics
  • Therapeutic target

ASJC Scopus subject areas

  • Molecular Medicine
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Bromodomain and extraterminal proteins - A novel class of therapeutic targets in epigenetics. / Chen, Jin Jing; Zhao, Xiao Li; Wang, Zhen; Chen, Lin-Feng.

In: Yaoxue Xuebao, Vol. 52, No. 8, 01.01.2017, p. 1209-1215.

Research output: Contribution to journalReview article

Chen, Jin Jing ; Zhao, Xiao Li ; Wang, Zhen ; Chen, Lin-Feng. / Bromodomain and extraterminal proteins - A novel class of therapeutic targets in epigenetics. In: Yaoxue Xuebao. 2017 ; Vol. 52, No. 8. pp. 1209-1215.
@article{dc75d41714664c7d94e7da34a432f98d,
title = "Bromodomain and extraterminal proteins - A novel class of therapeutic targets in epigenetics",
abstract = "Bromodomain and extraterminal (BET) proteins are a class of proteins that can interpret epigenetic codes and play an important role in regulating gene transcription through identifying and binding acetylated histones or non-histones proteins. The BET inhibitors have emerged with good therapeutic effects in preclinical disease models such as cancer and inflammation. Some of them have entered clinical studies, demonstrating that there is considerable prospect for drug development with BET as a potential therapeutic target. This review briefly describes the structures and functions of the BET proteins, the BET inhibitors in various diseases, as well as molecular mechanisms involved.",
keywords = "Bromodomain and extraterminal, Bromodomain containing 4, Chromatin regulation, Epigenetics, Therapeutic target",
author = "Chen, {Jin Jing} and Zhao, {Xiao Li} and Zhen Wang and Lin-Feng Chen",
year = "2017",
month = "1",
day = "1",
doi = "10.16438/j.0513-4870.2017-0143",
language = "English (US)",
volume = "52",
pages = "1209--1215",
journal = "Yao xue xue bao = Acta pharmaceutica Sinica",
issn = "0513-4870",
publisher = "Zhonghua Yixuehui Zazhishe",
number = "8",

}

TY - JOUR

T1 - Bromodomain and extraterminal proteins - A novel class of therapeutic targets in epigenetics

AU - Chen, Jin Jing

AU - Zhao, Xiao Li

AU - Wang, Zhen

AU - Chen, Lin-Feng

PY - 2017/1/1

Y1 - 2017/1/1

N2 - Bromodomain and extraterminal (BET) proteins are a class of proteins that can interpret epigenetic codes and play an important role in regulating gene transcription through identifying and binding acetylated histones or non-histones proteins. The BET inhibitors have emerged with good therapeutic effects in preclinical disease models such as cancer and inflammation. Some of them have entered clinical studies, demonstrating that there is considerable prospect for drug development with BET as a potential therapeutic target. This review briefly describes the structures and functions of the BET proteins, the BET inhibitors in various diseases, as well as molecular mechanisms involved.

AB - Bromodomain and extraterminal (BET) proteins are a class of proteins that can interpret epigenetic codes and play an important role in regulating gene transcription through identifying and binding acetylated histones or non-histones proteins. The BET inhibitors have emerged with good therapeutic effects in preclinical disease models such as cancer and inflammation. Some of them have entered clinical studies, demonstrating that there is considerable prospect for drug development with BET as a potential therapeutic target. This review briefly describes the structures and functions of the BET proteins, the BET inhibitors in various diseases, as well as molecular mechanisms involved.

KW - Bromodomain and extraterminal

KW - Bromodomain containing 4

KW - Chromatin regulation

KW - Epigenetics

KW - Therapeutic target

UR - http://www.scopus.com/inward/record.url?scp=85041909255&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85041909255&partnerID=8YFLogxK

U2 - 10.16438/j.0513-4870.2017-0143

DO - 10.16438/j.0513-4870.2017-0143

M3 - Review article

AN - SCOPUS:85041909255

VL - 52

SP - 1209

EP - 1215

JO - Yao xue xue bao = Acta pharmaceutica Sinica

JF - Yao xue xue bao = Acta pharmaceutica Sinica

SN - 0513-4870

IS - 8

ER -